<?xml version="1.0" encoding="UTF-8"?>
<p class="p">Our study uncovered significant elevation of SM d18:1/16:0, a major species of SM, in 
 <italic class="italic">ep</italic> mice compared with WT mice. While SM d18:1/17:0, d18:1/21:1, and d18:1/21:0 were decreased in the 
 <italic class="italic">pa</italic> group (
 <xref ref-type="fig" rid="F5" class="xref">Figure 5</xref>C,D). Studies have shown that short- and medium-chain fatty acid SMs are positively correlated with intra-abdominal fat and insulin [
 <xref rid="B51" ref-type="bibr" class="xref">51</xref>]. An increase in sphingolipids can reduce the reverse cholesterol transport, thereby increasing the risk of hyperlipidemia-related diseases [
 <xref rid="B52" ref-type="bibr" class="xref">52</xref>]. Some specific lipid substances such as SM, Cer, and glycosphingolipid may have an atherogenic effect [
 <xref rid="B32" ref-type="bibr" class="xref">32</xref>]. An increase in SM d18:1/16:0 in 
 <italic class="italic">ep</italic> mice may be associated with the pro-atherosclerosis effect observed in these mice.
</p>
